← All Aclarion, INC filings

Aclarion, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion CSO Ryan Bond Receives Equity Grant
Aclarion, Inc. Chief Strategy Officer Ryan Bond was granted 55,000 restricted stock units vesting in June 2027.
NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion Executive Chairman Receives RSU Grant
Aclarion, Inc. Executive Chairman Jeffrey John Thramann was granted 100,000 restricted stock units vesting in 2027.
NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion Director David Neal Receives RSU Grant
Aclarion, Inc. director David K. Neal was granted 20,000 restricted stock units as part of the company's equity incentive plan.
NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion Director Receives Equity Grant
Director Stephen Deitsch was granted 20,000 restricted stock units in Aclarion, Inc. as part of the company's equity incentive plan.
NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion Director Scott Breidbart Purchases Shares
Director Scott Breidbart acquired 5,664 shares of Aclarion, Inc. common stock on the open market.
NASDAQ
ACON
Aclarion, INC
Form 4: Insider Buys 2,500 Aclarion Shares
Director David K. Neal acquired 2,500 shares of Aclarion common stock for $3.10 per share.
NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion Inc. Insider Buys Shares
Aclarion, Inc. reports a significant stock purchase by its CEO and Director, Brent Ness.
NASDAQ
ACON
Aclarion, INC
Form 4: Director William Wesemann Increases Stake in Aclarion
Aclarion, Inc. Director William Wesemann purchased 1,562 shares of common stock on the open market.
NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion CEO Boosts Stake with Share Purchase
Aclarion, Inc.'s Chief Executive Officer and Director, Brent Ness, acquired 10 shares of common stock on the open market at $6.2 per share.
NASDAQ
ACON
Aclarion, INC
Form 4: Aclarion CFO Gould Granted 17,000 Stock Options
Aclarion, Inc.'s CFO, Gregory A. Gould, was granted 17,000 stock options with an exercise price of $7.15, vesting over four years.